• HR-LCMS/MS Reveals Astragalus dasyanthus as a Glabrol Source

  2026-05-24

  This study introduces a streamlined HR-LCMS/MS-based workflow for rapid identification of autophagy-inducing compounds in plant extracts. The authors demonstrate the method's utility by discovering Astragalus dasyanthus as a novel producer of glabrol, with implications for autophagy and metabolic research.

• Intestinal TM6SF2 Deficiency Drives MASH via the Gut–Liver A

  2026-05-23

  This study uncovers that loss of TM6SF2 specifically in intestinal epithelial cells promotes metabolic dysfunction-associated steatohepatitis (MASH) by disrupting gut barrier integrity, altering microbiota, and elevating lysophosphatidic acid (LPA) signaling. These findings reveal a mechanistic link between intestinal lipid metabolism and liver inflammation, highlighting new avenues for therapeutic intervention targeting the gut–liver axis.

• Tetraethylammonium Chloride: Applied Workflows in Vascular a

  2026-05-22

  Tetraethylammonium chloride (TEAC) enables high-resolution dissection of potassium channel pathways, giving researchers precision control in vascular and metabolic experiments. Leveraging APExBIO’s high-purity TEAC, scientists can streamline protocols, probe channelopathies, and troubleshoot challenging ion conduction assays with data-driven confidence.

• Synergistic Induction of Cell Death in RCC via SGI-1027 and

  2026-05-22

  This study demonstrates that combining the methuosis inducer SGI-1027 with the mTOR inhibitor everolimus induces both apoptosis and pyroptosis in renal cancer cells by disrupting lysosomal membrane integrity. The findings provide new mechanistic insights and highlight a promising therapeutic strategy to overcome drug resistance in advanced renal cell carcinoma.

• 5-Methyl-CTP: Enhancing mRNA Synthesis for Advanced Vaccines

  2026-05-21

  5-Methyl-CTP empowers researchers to synthesize mRNA with superior stability and translation efficiency, driving innovations in vaccine platforms and gene expression analysis. Explore cutting-edge workflows, troubleshooting insights, and real-world applications that set this modified nucleotide apart in mRNA-based drug development.

• Ridaforolimus: Applied Protocols for mTOR Inhibition in Canc

  2026-05-21

  Ridaforolimus (Deforolimus, MK-8669) is a selective mTOR inhibitor enabling robust, reproducible workflows for apoptosis, proliferation, and angiogenesis studies in cancer research. This guide delivers protocol refinements, troubleshooting strategies, and integration of recent machine learning-driven senolytic insights for maximum experimental reliability.

• Tetraethylammonium Chloride: Precision in K+ Channel Researc

  2026-05-20

  Tetraethylammonium chloride (TEAC) empowers researchers to interrogate potassium channel function with unmatched specificity, supporting both classic and emerging applications in physiology and pharmacology. This guide unpacks experimental workflows, troubleshooting strategies, and actionable insights for maximizing reproducibility and selectivity in ion conduction and vascular research.

• Lactobacillus gasseri Modulates Colitis via NR1I3-E-cadherin

  2026-05-20

  Qian et al. (2024) demonstrate that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by regulating E-cadherin expression through the NR1I3 pathway. This mechanistic insight clarifies how targeted probiotic intervention can reinforce the intestinal barrier, offering a foundation for novel IBD therapies.

• 7-AAD Cell Viability Assay Kit: Precision in Apoptosis and N

  2026-05-19

  Explore the advanced science behind the 7-AAD Cell Viability Assay Kit for apoptosis and necrosis detection. This article unpacks the unique spectral and mechanistic advantages of 7-amino actinomycin D assays, integrating new structural insights from CAR-T research for informed experimental design.

• Omeprazole (A2845): Protocols for H+,K+-ATPase Inhibition Re

  2026-05-19

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor designed for controlled manipulation of gastric acid secretion in preclinical and mechanistic research settings. It is best suited for in vitro and ex vivo models of gastric acid-related disorders and antiulcer activity studies, but is not intended for diagnostic, therapeutic, or prolonged storage applications.

• Perphenazine: Dopamine D2 Receptor Antagonist in Advanced Re

  2026-05-18

  Perphenazine, a potent dopamine D2 receptor antagonist, enables robust modeling in neuropharmacology, mitochondria-mediated cell death, and host-directed antibacterial research. This article breaks down experimental workflows, protocol refinements, and troubleshooting strategies leveraging APExBIO’s high-purity Perphenazine for reproducible, high-impact studies.

• Screening MMV Compounds for Activity Against MDR Bacteria an

  2026-05-18

  This study systematically evaluated the MMV Pandemic Response Box for agents active against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and key fungal pathogens. The findings highlight several compounds with bactericidal or fungicidal activity in vitro, informing future drug development and antibacterial assay design.

• Otilonium Bromide: Antimuscarinic Agent for Cholinergic Rese

  2026-05-17

  Otilonium Bromide is a high-purity antimuscarinic agent used to inhibit acetylcholine receptors in neuroscience and smooth muscle research. Its efficacy in modulating cholinergic signaling pathways is well-documented, making it a preferred tool for in vitro experimental protocols. APExBIO supplies Otilonium Bromide (SKU: B1607) in powder and solution formats for reliable, reproducible results.

• Methylation, Folate Antagonists, and Neurological Disorders:

  2026-05-16

  This review synthesizes the biochemical and clinical intersections of methylation, folate metabolism, and neuropsychiatric disease, highlighting the unique role of S-adenosylmethionine (SAMe) and the consequences of its disruption. The findings underscore how deficiencies in folate or vitamin B12 can alter CNS methylation, with direct relevance for research into folate antagonists such as methotrexate.

• Novobiocin: Advanced Assay Guidance and Biotechnological Ins

  2026-05-15

  Explore Novobiocin, a potent aminocoumarin antibiotic, through the lens of advanced assay design and biotechnological innovation. This article delivers in-depth, evidence-based guidance for researchers seeking optimal use and scientific context beyond standard protocols.

15604 records 1/1041 page Next 12345 下5页 Last page